Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Nasenbalsam (Ointment) 1 D Ointment is a Health Canada–registered human drug (DIN 02186446) held by Wala Heilmittel GmbH, containing Eucalyptus. Health Canada lists its status as Cancelled Post Market (status date 03 Aug 2007). Nexara Health has matched 3 registrations of Eucalyptus across 1 other regulated market.

Health Canada registration

DIN02186446
Brand nameNasenbalsam (Ointment)
Active ingredientEucalyptus
Strength1 D
Dosage formOintment
RouteNasal ; Topical
CompanyWala Heilmittel GmbH
StatusCancelled Post Market — 03 Aug 2007
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Eucalyptus registered in other markets

3 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesEucalyptus Globulus PollenALK-Abello, Inc.Injection, SolutionlistedFDA NDC
United StatesEucalyptus Globulus PollenALK-Abello, Inc.Injection, SolutionlistedFDA NDC
United StatesEucalyptus Globulus PollenALK-Abello, Inc.Injection, SolutionlistedFDA NDC

See every manufacturer of Eucalyptus worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Nasenbalsam (Ointment) (DIN 02186446) marketed in Canada?

No. Health Canada lists DIN 02186446 as Cancelled Post Market as of 03 Aug 2007.

Who holds the Canadian licence for this product?

Wala Heilmittel GmbH is the company of record in the Health Canada Drug Product Database.

Is Eucalyptus registered outside Canada?

Yes — Nexara Health has matched 3 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02186446, status date 2007-08-03; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02186446, status date 2007-08-03; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02186446, status date 2007-08-03; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.